Navigation Links
Study in mice discovers injection of heat-generating cells reduces belly fat
Date:9/5/2012

COLUMBUS, Ohio The injection of a tiny capsule containing heat-generating cells into the abdomens of mice led those animals to burn abdominal fat and initially lose about 20 percent of belly fat after 80 days of treatment.

Researchers conducting the study were surprised to see that the injected cells even acted like "missionaries," converting existing belly fat cells into so-called thermogenic cells, which use fat to generate heat.

Over time, the mice gained back some weight. But they resisted any dramatic weight gain on a high-fat diet and burned away more than a fifth of the cells that make up their visceral fat, which surrounds the organs and is linked to higher risk for Type 2 diabetes, cancer and heart disease.

The scientists took advantage of the heat-generating properties of a so-called good fat in the body, brown fat, to cut back on the white fat cells that compose the visceral fat that tends to accumulate in the belly.

(See related news release at http://researchnews.osu.edu/archive/visceralfat.htm.)

The scientists combined those brown fat thermogenic cells with genetically modified cells missing an enzyme that leads to visceral fat growth. The engineered cells were placed inside a gel-like capsule that allowed for release of its contents without triggering an immune response.

"With a very small number of cells, the effect of the injection of this capsule was more pronounced at the beginning, when the mice dramatically lost about 10 percent of their weight. They gained some weight back after that. But then we started to look at how much visceral fat was present, and we saw about a 20 percent reduction in those lipids. Importantly, other nontreated peripheral or subcutaneous fat, which has some beneficial health effects, remained the same. That's what we want," said Ouliana Ziouzenkova, assistant professor of human n
'/>"/>

Contact: Ouliana Ziouzenkova
Ziouzenkova.1@osu.edu
614-292-5034
Ohio State University
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Study: How a high-fat diet and estrogen loss leads women to store more abdominal fat than men
2. Brainy beverage: Study reveals how green tea boosts brain cell production to aid memory
3. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
4. Study identifies prime source of ocean methane
5. New Nature study illuminates 55 million years of the carbon cycle and climate history
6. GW professor receives grant to study the role of genes in drug addiction
7. Study shows hope of greater global food output, less environmental impact of agriculture
8. Controlling gait of horses may be possible, says key study from Texas A&M
9. New study evaluates noninvasive technology to determine heart disease
10. Zebrafish study explains why the circadian rhythm affects your health
11. University of Tennessee Team receives NSF support to study toxic water in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ... Iris Recognition Market 2015-2019" report to their offering. ... market to grow at a CAGR of 23.5 percent ... the present scenario and the growth prospects of the ... calculate the market size, the report considers the revenue ...
(Date:3/24/2015)... GARDENS, Fla. , March 24, 2015 /PRNewswire/ ... identity management solutions, today announced that its U.are.U ... clothing accessory retailer Goorin Bros . to ... Crossmatch biometrics-based solution secures access to the POS ... the increased risk of data breaches. ...
(Date:3/23/2015)... -- In the 2014 fiscal year, irs.gov recorded over $100 ... accounts for a fraction of the estimated losses for ... $11 billion globally. The polygraph has traditionally been used ... Investor Mark Saint Juste along with former ... partnered to administer the test in a new way: ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... ALLENTOWN, N.J. , April 3, 2013 HireLifeScience.com, the ... host its 4 th annual career fair at The ... on October 1, 2013.  Doors will open for ... at 4 p.m.  The event is being sponsored by Actavis, ...
... technology vital for tapping much-needed energy or one that,s environmentally ... explore at the Technology and Society Forum session on fracking ... Campus Center Ballroom. The NJIT Technology and Society Forum ... for hydraulic fracturing, injects fluid underground at high pressure to ...
... Laboratory (NPL), the UK,s National Measurement Institute, could help ... injuries such as muscle strains and ligament damage. ... in physiotherapy to accelerate healing of tissue injuries. Ideally, ... treatment site, but it is well-known that this does ...
Cached Biology News:Registration Now Open for Elite Life Science Career Fair 2Fracking: Challenges and opportunities 2Measuring ultrasound for better treatment of muscle injuries 2
(Date:4/16/2015)... Regis Technologies looks forward to being part ... (AACR) annual meeting. Regis will exhibit at this year's ... 18, in Philadelphia and running through April 22, 2015. ... oldest and largest organization focused on cancer research. It ... with survivors to promote awareness and research funding. ...
(Date:4/16/2015)... April 16, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... Exchange: PBT.U), is pleased to announce that the Company ... April 25, 2015 to be held in ... Bailey and Mr. James Mellon , a ... update on the key programs at its subsidiaries, Portage ...
(Date:4/16/2015)... SAN DIEGO , April 16, 2015 /PRNewswire/ ... and development of therapeutic antibodies, today announced ... (IL-36R) antibody program into IND-enabling studies. The ... a novel treatment for generalized pustular psoriasis ... high unmet medical need. ANB019 is wholly owned ...
(Date:4/16/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company ... new orphan drug indications, today announced that the ... a clinical trial site for the ongoing, multicenter Phase ... multiforme (GBM), the most common and deadly form of ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2Portage to Present at Master Investor 2015 in London, UK 2Portage to Present at Master Investor 2015 in London, UK 3Portage to Present at Master Investor 2015 in London, UK 4AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5
... Jan. 22 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. (TSX:,LOR; ... research and,development of pharmaceutical products and technologies for ... strengthened its management team,with the appointment of Mr. ... (CFO)., Mr. Korth has previously held senior ...
... of Record for FOSRENOL(R), SARATOGA SPRINGS, N.Y., Jan. ... company, is pleased to announce that Shire,Pharmaceuticals (LSE: SHP, ... record to lead the professional advertising and promotion for,Shire,s ... "We are excited to put our team,s experience ...
... N.J., Jan. 22 Ikaria Holdings, Inc., a ... S. Zoth has been elected as an independent ... the former Chief Financial Officer of,MedImmune, will chair ... fortunate to have an executive with Lota,s background ...
Cached Biology Technology:Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer 2Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer 3Shire Engages Palio 2Shire Engages Palio 3Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair 2
... ANTI-RNase is a protein ribonuclease inhibitor that noncovalently ... No inhibition is seen with RNase 1, T1, ... distinct from human placental ribonuclease inhibitor in that ... and does not release active RNase in the ...
...
UGT1A7 (E-15)...
... nucleofection of optimized cell lines in combination ... nucleofection parameters. Nucleofector Kits are only functional ... cell lines can be transfected with this ... given in brackets in percent (Efficiency [%] ...
Biology Products: